CELLBRICATE
LIVE

Serial Number

79458970

Owner

TQ Therapeutics GmbH

Filing Date

Aug 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CELLBRICATE Trademark

Serial Number: 79458970

CELLBRICATE is a trademark filed by TQ Therapeutics GmbH on August 5, 2026. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TQ Therapeutics GmbH (5 trademarks)

Hermine-von-Parish-Straße 96

Entity Type: 98

Trademark Details

Filing Date

August 5, 2026

Registration Date

Not Registered

Goods & Services

Laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; laboratory apparatus for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, the apparatus including a body fluid collection unit, a cell processing unit and a unit for releasing the manufactured cellular therapy unit; scientific apparatus for the washing of cells obtained from a biological sample, in particular for washing of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; laboratory apparatus for the manufacture of cellular therapy products including apparatus for the chromatographic immobilization, purification or isolations of cells, apparatus of activation or stimulation of cells, and apparatus for the transfer of genes into cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.

Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research; chemical reagents for the manufacture of cellular therapy products, in particular of cellular therapy products based on body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for biological analysis of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; kits containing chemical reagents for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents for the stimulation and/or expansion of T-cells, B-cells or natural killer cells; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for the activation or stimulation of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.

Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 25, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2026 REPR